MASH
Eli Lilly shares results for tirzepatide for MASH resolution
June 10, 2024Research and Development Eli Lilly, Hepatology, MASH, clinical trial, liver
Eli Lilly has announced results from the phase 2 SYNERGY-NASH study which assessed 190 patients, with or without type 2 …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
